09 June 2000
Post-Transplantation Histology as Surrogate Markerfor Long-Term Kidney Allograft Outcome
Serdar Yilmaz, Mark Nutley, Eero Taskinen, Timo Paavonen, Pekka HayryAnn Transplant 2000; 5(2): 37-43 :: ID: 497524
Abstract
Apart of death with functioning transplant, which is mostly related to cardiovascular complications, poor long-term survivalof renal transplants has been related to chronic rejection. In Dunn's series, the most common cause of kidney graft lossbeyond 2yearswas chronic rejection (36.2%), followed by noncompliance (27.6%), death with a functioning transplant (22%), and acute rejection (8.6%) [1]. Ferguson reported an overall incidence of chronic kidney allograft rejection of 23% over a 3 to 10-year follow-up [2]. Graft failure due to chronic rejection is the leading cause of the estimated yearly 6-12% graft loss after the first year [3]. Chronic rejection does not affect patient survival,but it has a significant effect on the5-yeargraftsurvival[4]...
Keywords: chronic rejection, Pathology, CADI
In Press
Original article
Diagnostic Utility of FAR1 Methylation Levels in Hepatocellular Carcinoma Patients Undergoing Liver Transpl...Ann Transplant In Press; DOI: 10.12659/AOT.951568
Original article
Inferior Long-Term Outcome of Fatty Liver Allografts After Orthotopic Liver TransplantationAnn Transplant In Press; DOI: 10.12659/AOT.950589
Database Analysis
Identification and Validation of Liver Transplantation-Induced Acute Lung Injury Biomarkers Using a Bioinfo...Ann Transplant In Press; DOI: 10.12659/AOT.950289
Original article
Survival and Recurrence in Liver Transplant Patients With Intrahepatic Cholangiocarcinoma and Hepatocellula...Ann Transplant In Press; DOI: 10.12659/AOT.950997
Most Viewed Current Articles
24 Aug 2021 : Review article 18,372
Normothermic Machine Perfusion (NMP) of the Liver – Current Status and Future PerspectivesDOI :10.12659/AOT.931664
Ann Transplant 2021; 26:e931664
05 Apr 2022 : Original article 14,731
Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver TransplantationDOI :10.12659/AOT.935604
Ann Transplant 2022; 27:e935604
22 Nov 2022 : Original article 14,244
Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...DOI :10.12659/AOT.937988
Ann Transplant 2022; 27:e937988
29 Dec 2021 : Original article 13,752
Efficacy and Safety of Tacrolimus-Based Maintenance Regimens in De Novo Kidney Transplant Recipients: A Sys...DOI :10.12659/AOT.933588
Ann Transplant 2021; 26:e933588